323 related articles for article (PubMed ID: 31367788)
21. Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.
Jan YH; Heck DE; Casillas RP; Laskin DL; Laskin JD
Chem Res Toxicol; 2015 Nov; 28(11):2091-103. PubMed ID: 26451472
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of the thioredoxin system from Methanosarcina acetivorans.
McCarver AC; Lessner DJ
FEBS J; 2014 Oct; 281(20):4598-611. PubMed ID: 25112424
[TBL] [Abstract][Full Text] [Related]
23. The relationship of the redox potentials of thioredoxin and thioredoxin reductase from Drosophila melanogaster to the enzymatic mechanism: reduced thioredoxin is the reductant of glutathione in Drosophila.
Cheng Z; Arscott LD; Ballou DP; Williams CH
Biochemistry; 2007 Jul; 46(26):7875-85. PubMed ID: 17550271
[TBL] [Abstract][Full Text] [Related]
24. Enzyme-linked immunospot assay for detection of thioredoxin and thioredoxin reductase secretion from cells.
Sahaf B; Söderberg A; Ekerfelt C; Paulie S; Rosén A
Methods Enzymol; 2002; 353():22-35. PubMed ID: 12078496
[TBL] [Abstract][Full Text] [Related]
25. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
Lemarechal H; Allanore Y; Chenevier-Gobeaux C; Ekindjian OG; Kahan A; Borderie D
Clin Chim Acta; 2006 May; 367(1-2):156-61. PubMed ID: 16458876
[TBL] [Abstract][Full Text] [Related]
26. The thioredoxin system in cancer.
Arnér ES; Holmgren A
Semin Cancer Biol; 2006 Dec; 16(6):420-6. PubMed ID: 17092741
[TBL] [Abstract][Full Text] [Related]
27. Thioredoxin system in cell death progression.
Lu J; Holmgren A
Antioxid Redox Signal; 2012 Dec; 17(12):1738-47. PubMed ID: 22530689
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Thioredoxin System as a Strategy for Cancer Therapy.
Bian M; Fan R; Zhao S; Liu W
J Med Chem; 2019 Aug; 62(16):7309-7321. PubMed ID: 30963763
[TBL] [Abstract][Full Text] [Related]
29. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of thioredoxin and thioredoxin reductase by 4-hydroxy-2-nonenal in vitro and in vivo.
Fang J; Holmgren A
J Am Chem Soc; 2006 Feb; 128(6):1879-85. PubMed ID: 16464088
[TBL] [Abstract][Full Text] [Related]
31. Securinine disturbs redox homeostasis and elicits oxidative stress-mediated apoptosis via targeting thioredoxin reductase.
Zhang J; Yao J; Peng S; Li X; Fang J
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):129-138. PubMed ID: 27777067
[TBL] [Abstract][Full Text] [Related]
32. The Thioredoxin System: A Promising Target for Cancer Drug Development.
Ghareeb H; Metanis N
Chemistry; 2020 Aug; 26(45):10175-10184. PubMed ID: 32097513
[TBL] [Abstract][Full Text] [Related]
33. Thiol-Based Antioxidants and the Epithelial/Mesenchymal Transition in Cancer.
Ogata FT; Simões Sato AY; Coppo L; Arai RJ; Stern AI; Pequeno Monteiro H
Antioxid Redox Signal; 2022 May; 36(13-15):1037-1050. PubMed ID: 34541904
[No Abstract] [Full Text] [Related]
34. Thioredoxin signaling as a target for cancer therapy.
Powis G; Kirkpatrick DL
Curr Opin Pharmacol; 2007 Aug; 7(4):392-7. PubMed ID: 17611157
[TBL] [Abstract][Full Text] [Related]
35. Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.
Yao A; Storr SJ; Al-Hadyan K; Rahman R; Smith S; Grundy R; Paine S; Martin SG
Mol Neurobiol; 2020 Jul; 57(7):2889-2901. PubMed ID: 32418115
[TBL] [Abstract][Full Text] [Related]
36. Advances in the Functions of Thioredoxin System in Central Nervous System Diseases.
Jia J; Xu G; Zhu D; Liu H; Zeng X; Li L
Antioxid Redox Signal; 2023 Feb; 38(4-6):425-441. PubMed ID: 35761787
[No Abstract] [Full Text] [Related]
37. Effects of Mammalian Thioredoxin Reductase Inhibitors.
Arnér ESJ
Handb Exp Pharmacol; 2021; 264():289-309. PubMed ID: 32767140
[TBL] [Abstract][Full Text] [Related]
38. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
[TBL] [Abstract][Full Text] [Related]
39. Upregulation of antioxidant thioredoxin by antidepressants fluoxetine and venlafaxine.
Bharti V; Tan H; Deol J; Wu Z; Wang JF
Psychopharmacology (Berl); 2020 Jan; 237(1):127-136. PubMed ID: 31473777
[TBL] [Abstract][Full Text] [Related]
40. Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum (II).
Sasada T; Nakamura H; Ueda S; Sato N; Kitaoka Y; Gon Y; Takabayashi A; Spyrou G; Holmgren A; Yodoi J
Free Radic Biol Med; 1999 Sep; 27(5-6):504-14. PubMed ID: 10490269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
